MedTrace Logo

Pilot Study of Organic Nitrates on Endothelial Function in CAD Patients

NCT01030367 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2009-12-11

No results posted yet for this study

Summary

Organic nitrates increase levels of circulating endothelial progenitor cells (Thum et al., Arterioscler Thromb Vasc Biol. 2007 Apr;27(4):748-54). Here, we want to test the effects of two different organic nitrates (PETN, ISDN) on number and function of endothelial progenitor cells and endothelial function.

Conditions

Interventions

DRUG

PETN, ISDN

Oral dosing of organic nitrates PETN 2x 80mg per day ISDN 2x40mg per day

Sponsors & Collaborators

  • Julius-Maximilians University

    lead OTHER

Principal Investigators

  • Thomas Thum, MD, PhD · University of Würzburg

Study Design

Allocation
NON_RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-01-31
Primary Completion
2008-11-30
Completion
2010-01-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01030367 on ClinicalTrials.gov